Stakeholders Urge CMS To Remove Conditions On Coverage Of PET For Cancer
This article was originally published in The Gray Sheet
Executive Summary
The National Oncologic PET Registry Working Group has strong support from industry and other stakeholders in its request that CMS end data collection requirements for coverage of positron emission tomography scans for cancer
You may also be interested in...
MedCAC Says PET Data Is Too Weak To Remove Registry Requirement
CMS should maintain its data collection requirements for coverage of positron emission tomography for nine cancers, because the evidence linking PET to improved outcomes is still weak, the Medicare Evidence Development and Coverage Advisory Committee concluded at its Aug. 20 meeting
MedCAC Says PET Data Is Too Weak To Remove Registry Requirement
CMS should maintain its data collection requirements for coverage of positron emission tomography for nine cancers, because the evidence linking PET to improved outcomes is still weak, the Medicare Evidence Development and Coverage Advisory Committee concluded at its Aug. 20 meeting
MedCAC for PET
Medicare Evidence Development and Coverage Advisory Committee will meet Aug. 20 in Baltimore to give CMS feedback on its open national coverage analysis of positron emission tomography scans. The agency is considering removing the data collection requirements it put in place in 2005 as conditions of coverage for PET scans for diagnosis, staging and restaging of brain, ovarian, prostate and certain other cancers (1"The Gray Sheet" June 2, 2008, p. 11). The scheduled MedCAC meeting pushes CMS' deadline for a proposed decision back two months to Jan. 10, 2009